SCHEMBL18200848

SCHEMBL18200848

c1ccc(-c2cc(-c3cccc(-c4nc5ccccc5c5c4ccc4ccccc45)c3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
HPGD P15428 6/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 4/20 0.43
LMNA P02545 6/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
GLA P06280 1/20 0.43
NTSR1 P30989 1/20 0.41
ACHE P22303 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
NPY1R P25929 1/20 0.39
HTT P42858 1/20 0.39
NPY2R P49146 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
PTGES O14684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18201247 0.97 MAPT (0.44) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18201242 0.97 MAPT (0.44) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18201244 0.97 MAPT (0.44) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18200588 0.96 MAPT (0.43) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18200489 0.96 MAPT (0.43) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18200431 0.96 MAPT (0.43) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18200585 0.96 MAPT (0.43) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18200367 0.96 MAPT (0.43) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18201106 0.96 MAPT (0.40) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL18200423 0.96 MAPT (0.40) MAPTHPGDALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MAPT 1937/4885HPGD 421/4885ALDH1A1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.